Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.
about
Endothelial-Leukocyte Interaction in Severe Malaria: Beyond the BrainVascular dysfunction as a target for adjuvant therapy in cerebral malariaEndothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral MalariaExperimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierNitric oxide synthase dysfunction contributes to impaired cerebroarteriolar reactivity in experimental cerebral malariaPathophysiological Mechanisms in Gaseous Therapies for Severe MalariaInhaled nitric oxide reduces endothelial activation and parasite accumulation in the brain, and enhances survival in experimental cerebral malariaIn vitro and in vivo silencing of plasmodial dhs and eIf-5a genes in a putative, non-canonical RNAi-related pathway.From METS to malaria: RRx-001, a multi-faceted anticancer agent with activity in cerebral malaria.Experimental Models of Microvascular Immunopathology: The Example of Cerebral Malaria.Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.Oxidative stress in malaria.A chronic scheme of cranial window preparation to study pial vascular reactivity in murine cerebral malaria.Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents.Integrin αDβ2 (CD11d/CD18) mediates experimental malaria-associated acute respiratory distress syndrome (MA-ARDS).Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.Imaging of small-animal models of infectious diseases.Apoptosis of non-parasitised red blood cells in Plasmodium yoelii malaria.Cerebral malaria: we have come a long wayHost matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity?Cerebral malaria--clinical manifestations and pathogenesis.Reactive nitrogen species as therapeutic targets for autophagy: implication for ischemic stroke.S-nitrosoglutathione prevents experimental cerebral malaria.Efficacy of combined atorvastatin and sildenafil in promoting recovery after ischemic stroke in mice.Cerebral tissue oxygenation impairment during experimental cerebral malaria.Looking through a cranial window: intravital microscopy for in vivo study of cerebral malaria.NO-Donor Dihydroartemisinin Derivatives as Multitarget Agents for the Treatment of Cerebral Malaria.Measurement of the uniaxial mechanical properties of rat brains infected by Plasmodium berghei ANKA.Leukocyte Infiltration Triggers Seizure Recurrence in a Rat Model of Temporal Lobe Epilepsy.
P2860
Q26778543-E0EE976D-2BF5-439C-B4B0-E79A3C81DD67Q27025436-2E4BF3CA-A804-4F1E-8507-05FF97D1D6ADQ27315202-98D46901-90AF-4290-98E7-F1669152F7B6Q27322655-1D8DC6DD-2455-499E-BB53-9B7DC0F778CCQ27334444-2862800F-FA81-4975-8F7F-3D4EAC129DCBQ28080030-AB3DD42A-3747-4B77-AA48-CC9D228A3A73Q28742640-3EC933EF-F8F9-4221-B7B9-B550057F797EQ34303004-A4A6D654-91CE-4BE8-8BD2-BA809CB09850Q35676444-EA40ED7A-106B-4DE9-B7E8-8BC1C64D6AF2Q36100829-FF63472A-8C20-4484-91A4-4FC0879C4537Q36209383-558A0B16-E94D-47FE-8FF3-0401130638EBQ36538402-A4EF2ACE-C590-4156-8C03-5DEAA1FC47EEQ36785159-B31A79CF-2553-454B-980A-AF33A845549BQ36785435-3AC7C68A-C695-4C37-B368-50E12D297058Q37139922-90B8996D-8DE6-48C6-98EC-62A4F6245B10Q37263464-7BD6F180-C140-49D0-8DC3-8132ABE48116Q37671857-FB00EFE3-A488-4AF5-BCC1-09EA08B6CB2EQ37675338-CCD5E7EB-44D5-42F4-B4C9-53238E45F380Q38047587-DCB58171-D0A5-4AFB-9D63-3E02C56AE12EQ38182192-46129581-C9BE-4DB0-99BD-1F5818B12D7CQ38690668-38CD1F53-DAE7-45FB-859E-FE7A8A70D84DQ38771268-1ABC99C3-8A6A-4C71-B803-FFBF50610BB6Q41820775-97265993-C8F8-4504-BE0B-9845521A135EQ41855130-06810E62-7543-4EEF-8350-AFBE1D6D3040Q41946015-490A4649-8E2D-4BE4-8961-0D5BAE05D5D1Q42524682-643C0C1C-88DC-4B8C-8B4E-487F6F205F16Q46227638-6506D0EF-A5B2-4900-AED5-63772CAC8CC3Q46531413-D0096000-2F43-4815-ABB1-5B6E384D85B5Q52142418-CE5C44D6-8082-4001-A42E-90890BC12DE6
P2860
Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Exogenous nitric oxide decreas ...... erghei ANKA infection in mice.
@ast
Exogenous nitric oxide decreas ...... erghei ANKA infection in mice.
@en
type
label
Exogenous nitric oxide decreas ...... erghei ANKA infection in mice.
@ast
Exogenous nitric oxide decreas ...... erghei ANKA infection in mice.
@en
prefLabel
Exogenous nitric oxide decreas ...... erghei ANKA infection in mice.
@ast
Exogenous nitric oxide decreas ...... erghei ANKA infection in mice.
@en
P2093
P2860
P356
P1476
Exogenous nitric oxide decreas ...... berghei ANKA infection in mice
@en
P2093
John A Frangos
Leonardo J M Carvalho
Wisam Barkho
P2860
P2888
P356
10.1186/1742-2094-8-66
P577
2011-06-07T00:00:00Z
P5875
P6179
1015252642